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During the drafting of one paper concerning the emergency
treatment of femoral pseudoaneurysm (PSA) rupture in
intravenous drug abusers (IVDA) with human immunodeﬁ-
ciency virus (HIV), we found, among latest articles, this
extremely interesting manuscript of Gansera et al about the
ethical, social, and economic aspects of cardiac surgery in this
particular niche of patients.
We treated, for inguinal hemorrhage from chronic infected
PSA, two HIV-positive IVDA with both femoral bifurcations
and forearms involved, by means of deployment of covered
stent grafts with hybrid technique. Drug abuse often leads to
dramatic clinical pictures not easy to solve.1
To stop bleeding,we obtained a quick access to the vascular
tree throughout a short surgical exposure in a healthy
segment of the distal superﬁcial femoral artery, reducing,
at the same time, the complexity of open surgical correction
and making life easier for both the surgeons and the health
care workers involved in the operating room.
Writing the discussion of our paper, not yet in knowledge
of this valuable document, we developed the same themes
here reported.
What to do when we have to face so complex and difﬁcult
cases? Is it ethical to refuse care independently from the
compliance of patients? And what about social costs for such
marginalized individuals? And last but not least, what about
the safety of the health care workers? These are enormous
issues for those who work in the operating theater and there
are no easy answers to such difﬁcult questions.
In our experience, the absolute need for emergency sur-
gery, when unstable hemodynamic conditions threaten a
patient’s life, paradoxically helped us throw our heart over
the fence and to carry out surgery without any hesitation.
As things settled down, we asked ourselves what to do in
IVDA asymptomatic patients or, on the opposite, in thosewho
had already undergone surgery and in incurables.
Probably we would be more pragmatic, and a little bit less
idealist, deﬁnitely postponing elective operation and avoid-
ing unnecessary overtreatment or dangerous heroism.
When discussing such particular and complicated cases,
health care workers security seems to be erroneously a
secondary issue. As human beings, fear of HIV infections is
justiﬁable although we are professionals and we are used to
face many cumbersome situations.
When planning surgical treatment for HIV/AIDS patients, the
surgical equipe should follow guidelines and adopt all safety
procedures to avoid adverse effects such as barrier protection,
protective eyewear, gloves, and water-impermeable gowns.2–4
Obviously, developing operative strategies to reduce
invasiveness and risk of contamination for the members
of the surgical team is mandatory. For example, in vascular
surgery the increasing use of endovascular treatment
allows us to reduce the need for open surgical repair in
case of hemorrhage.5,6
The economic burden of thesehigh-risk surgical procedures
in such odd, erratic, and sometimes even criminal patients is
another fundamentalmatter. The analysis should consider in a
whole—not only the direct costs of thepersonnel and advanced
materials but also the social price of advanced therapies, length
of stay, treatments of complications, and readmissions. Mor-
tality, morbidity, procedure time, blood loss, intensive cure,
and hospitalization times are lower when less invasive proce-
dures are preferred despite higher costs of devices.
Surely,wewillﬁnd “devotes”of treatment at anyprice against
partisans of absolute denial of treatment of this kind of patients.
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Weareall awareof thedifﬁculties involved inharmonizing those
positions but as ever “in medio stat virtus.”
If the core of Hippocrates oath is our promise, when we
become doctors, to do everything possible to help our pa-
tients, not all the cases of HIV-positive IVDA patients or AIDS
could be eligible for an elective treatment if theydo not decide
tomake a change in their lifestyle. It’s fundamental beginning
a drug addiction treatment and recovery according to age,
drug use history, and other medical or psychiatric conditions
with the help of doctors, psychologists, social workers, coun-
selors, or whoever offers addiction treatment services.
A completely different approach must be adopted in case of
impelling conditions or evident emergency. In these cases no “ifs
and/or buts” exist and our duty is to save lives and give almost a
chance to everyone. The only exceptions to this diligence could
be the treatment of “missions impossible” cases or patients in
terminal conditionswhen the trespass of good clinical practice is
unethical, dangerous, and waste of money.
In the end we must thank Gansera and all the invited
colleagues for commentaries who have turned on the lights
on a so delicate issue that can suddenly materialize in our
everyday praxis.
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